SMTL ID : 5ghv.2 (1 other biounit)

Crystal structure of an inhibitor-bound Syk

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x X5G: 1-({1-[2-({3,5-dimethyl-4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}amino)pyrimidin-4-yl]-4-methyl-1H-pyrrol-3-yl}methyl)azetidin-3-ol(Non-covalent)

X5G.1: 14 residues within 4Å: Chain A: L.22, A.45, M.93, E.94, M.95, A.96, E.97, L.98, G.99, P.100, R.143, N.144, L.146, D.157 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.22, A:A.45, A:L.146 Hydrogen bonds: A:A.96, A:A.96 Salt bridges: A:D.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lee, S.J. et al., Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs. Febs J. (2016)

Release Date

2016-07-06

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence